BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND HMGA1, MGC4242, 3159, ENSG00000137309, MGC12816, HMGIY, P17096, MGC4854, HMG-R
23 results:

  • 1. The role of high mobility group AT-hook 1 in viral infections: Implications for cancer pathogenesis.
    Akade E; Jalilian S
    Int J Biochem Cell Biol; 2024 Apr; 169():106532. PubMed ID: 38278412
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Circ_UBAP2 exacerbates proliferation and metastasis of OS via targeting miR-665/miR-370-3p/hmga1 axis.
    Ma W; Gao Y; Yao X; Zhang J; Jia L; Wang D; Lin L; Bi LJ; Xu Q
    Environ Toxicol; 2024 Jan; 39(1):212-227. PubMed ID: 37676907
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. LncRNA LINC00467 contributes to osteosarcoma growth and metastasis through regulating hmga1 by directly targeting miR-217.
    Ma HZ; Wang J; Shi J; Zhang W; Zhou DS
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):5933-5945. PubMed ID: 32572906
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. hmga1/E2F1 axis and NFkB pathways regulate LPS progression and trabectedin resistance.
    Loria R; Laquintana V; Bon G; Trisciuoglio D; Frapolli R; Covello R; Amoreo CA; Ferraresi V; Zoccali C; Novello M; Del Bufalo D; Milella M; Biagini R; D'Incalci M; Falcioni R
    Oncogene; 2018 Nov; 37(45):5926-5938. PubMed ID: 29980789
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Identification of key microRNAs, transcription factors and genes associated with congenital obstructive nephropathy in a mouse model of megabladder.
    Xin G; Chen R; Zhang X
    Gene; 2018 Apr; 650():77-85. PubMed ID: 29410288
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The High Mobility Group A1 (hmga1) gene is highly overexpressed in human uterine serous carcinomas and carcinosarcomas and drives Matrix Metalloproteinase-2 (MMP-2) in a subset of tumors.
    Hillion J; Roy S; Heydarian M; Cope L; Xian L; Koo M; Luo LZ; Kellyn K; Ronnett BM; Huso T; Armstrong D; Reddy K; Huso DL; Resar LMS
    Gynecol Oncol; 2016 Jun; 141(3):580-587. PubMed ID: 27001612
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A translocation t(6;14) in two cases of leiomyosarcoma: Molecular cytogenetic and array-based comparative genomic hybridization characterization.
    de Graaff MA; de Jong D; Briaire-de Bruijn IH; Hogendoorn PC; Bovée JV; Szuhai K
    Cancer Genet; 2015 Nov; 208(11):537-44. PubMed ID: 26361850
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Molecular cytogenetics of pediatric adipocytic tumors.
    Dadone B; Refae S; Lemarié-Delaunay C; Bianchini L; Pedeutour F
    Cancer Genet; 2015 Oct; 208(10):469-81. PubMed ID: 26319758
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Comparison of outcomes in early stage uterine carcinosarcoma and uterine serous carcinoma.
    Desai NB; Kollmeier MA; Makker V; Levine DA; Abu-Rustum NR; Alektiar KM
    Gynecol Oncol; 2014 Oct; 135(1):49-53. PubMed ID: 25084509
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Outcome of advanced, unresectable conventional central chondrosarcoma.
    van Maldegem AM; Gelderblom H; Palmerini E; Dijkstra SD; Gambarotti M; Ruggieri P; Nout RA; van de Sande MA; Ferrari C; Ferrari S; Bovée JV; Picci P
    Cancer; 2014 Oct; 120(20):3159-64. PubMed ID: 24995550
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. MiR-142-3p functions as a potential tumor suppressor in human osteosarcoma by targeting hmga1.
    Xu G; Wang J; Jia Y; Shen F; Han W; Kang Y
    Cell Physiol Biochem; 2014; 33(5):1329-39. PubMed ID: 24803022
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A protein array screen for Kaposi's sarcoma-associated herpesvirus LANA interactors links LANA to TIP60, PP2A activity, and telomere shortening.
    Shamay M; Liu J; Li R; Liao G; Shen L; Greenway M; Hu S; Zhu J; Xie Z; Ambinder RF; Qian J; Zhu H; Hayward SD
    J Virol; 2012 May; 86(9):5179-91. PubMed ID: 22379092
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Silencing of hmga1 expression by RNA interference suppresses growth of osteogenic sarcoma.
    Yuan S; Pan Q; Fu C; Bi Z
    Mol Cell Biochem; 2011 Sep; 355(1-2):281-7. PubMed ID: 21573994
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Sclerosing epithelial fibrosarcoma: a clinico-morphological evaluation of 10 cases].
    Blizniukov OP; Smirnova EA
    Vopr Onkol; 2009; 55(5):586-93. PubMed ID: 20020654
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Malignant ectomesenchymoma: genetic profile reflects rhabdomyosarcomatous differentiation.
    Floris G; Debiec-Rychter M; Wozniak A; Magrini E; Manfioletti G; De Wever I; Tallini G; Sciot R
    Diagn Mol Pathol; 2007 Dec; 16(4):243-8. PubMed ID: 18043289
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Imaging features of pulmonary Kaposi sarcoma-associated immune reconstitution syndrome.
    Godoy MC; Rouse H; Brown JA; Phillips P; Forrest DM; Müller NL
    AJR Am J Roentgenol; 2007 Oct; 189(4):956-65. PubMed ID: 17885071
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. HMGA proteins in malignant peripheral nerve sheath tumor and synovial sarcoma: preferential expression of HMGA2 in malignant peripheral nerve sheath tumor.
    Hui P; Li N; Johnson C; De Wever I; Sciot R; Manfioletti G; Tallini G
    Mod Pathol; 2005 Nov; 18(11):1519-26. PubMed ID: 16056249
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Molecular mechanism of hmga1 deregulation in human neuroblastoma.
    Giannini G; Cerignoli F; Mellone M; Massimi I; Ambrosi C; Rinaldi C; Gulino A
    Cancer Lett; 2005 Oct; 228(1-2):97-104. PubMed ID: 15923078
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Differential expression of hmga1 and HMGA2 in dermatofibroma and dermatofibrosarcoma protuberans: potential diagnostic applications, and comparison with histologic findings, CD34, and factor XIIIa immunoreactivity.
    Li N; McNiff J; Hui P; Manfioletti G; Tallini G
    Am J Dermatopathol; 2004 Aug; 26(4):267-72. PubMed ID: 15249855
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Case-control study evaluating the homogeneity and heterogeneity of risk factors between sinonasal and nasopharyngeal cancers.
    Zhu K; Levine RS; Brann EA; Hall HI; Caplan LS; Gnepp DR
    Int J Cancer; 2002 May; 99(1):119-23. PubMed ID: 11948502
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.